Department of Anesthesia, Centre of Head and Orthopedics, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
Scand J Trauma Resusc Emerg Med. 2010 Dec 7;18:65. doi: 10.1186/1757-7241-18-65.
Trauma is the leading cause of loss of life expectancy worldwide. In the most seriously injured patients, coagulopathy is often present on admission. Therefore, transfusion strategies to increase the ratio of plasma (FFP) and platelets (PLT) to red blood cells (RBC), simulating whole blood, have been introduced. Several studies report that higher ratios improve survival in massively bleeding patients. Here, the aim was to investigate the potential effect of increased FFP and PLT to RBC on mortality in trauma patients.
In a retrospective before and after study, all trauma patients primarily admitted to a level-one Trauma Centre, receiving blood transfusion, in 2001-3 (n = 97) and 2005-7 (n = 156), were included. In 2001-3, FFP and PLT were administered in accordance with the American Society of Anesthesiologists (ASA) guidelines whereas in 2005-7, Hemostatic Control Resuscitation (HCR) entailing pre-emptive use of FFP and PLT in transfusion packages during uncontrolled haemorrhage and thereafter guided by thrombelastograph (TEG) analysis was employed. The effect of transfusion therapy and coagulopathy on mortality was investigated.
Patients included in the early and late period had comparable demography, injury severity score (ISS), admission hematology and coagulopathy (27% vs. 34% had APTT above normal). There was a significant change in blood transfusion practice with shorter time interval from admission to first transfusion (median time 3 min vs.28 min in massive bleeders, p < 0.001), transfusion of higher ratios of FFP:RBC, PLT:RBC and PLT:FFP in the HCR group but 30-day mortality remained comparable in the two periods. In the 2005-7 period, higher age, ISS and Activated Partial Thromboplastin Time (APTT) above normal were independent predictors of mortality whereas no association was fund between blood product ratios and mortality.
Aggressive administration of FFP and PLT did not influence mortality in the present trauma population.
创伤是全球范围内导致预期寿命缩短的主要原因。在伤势最严重的患者中,入院时通常存在凝血功能障碍。因此,引入了增加血浆(FFP)和血小板(PLT)与红细胞(RBC)的比例以模拟全血的输血策略。有几项研究报告称,更高的比例可提高大量出血患者的生存率。在这里,目的是研究增加 FFP 和 PLT 与 RBC 的比例对创伤患者死亡率的潜在影响。
在一项回顾性前后研究中,纳入了 2001 年 3 月(n = 97)和 2005 年 7 月(n = 156)期间最初收治于一级创伤中心并接受输血的所有创伤患者。在 2001 年 3 月,FFP 和 PLT 的使用遵循美国麻醉医师协会(ASA)指南,而在 2005 年 7 月,采用止血控制复苏(HCR),即在不受控制的出血期间预先使用 FFP 和 PLT 输血,并根据血栓弹性图(TEG)分析进行指导。研究了输血治疗和凝血功能障碍对死亡率的影响。
早期和晚期纳入的患者具有相似的人口统计学特征、损伤严重程度评分(ISS)、入院时的血液学和凝血功能障碍(27%比 34%的患者 APTT 高于正常)。输血实践发生了显著变化,从入院到首次输血的时间间隔更短(大量出血患者的中位数时间为 3 分钟比 28 分钟,p < 0.001),HCR 组的 FFP:RBC、PLT:RBC 和 PLT:FFP 比例更高,但两个时期的 30 天死亡率相似。在 2005 年 7 月期间,较高的年龄、ISS 和高于正常的活化部分凝血活酶时间(APTT)是死亡率的独立预测因素,而血液制品比例与死亡率之间没有关联。
在本研究的创伤人群中,积极给予 FFP 和 PLT 并未影响死亡率。